Clinical Trial Update: Long-term Use of Romidepsin in Patients With CTCL

View source ↗

Summary

Clinical trial update on long-term use of romidepsin in patients with cutaneous T-cell lymphoma. The study is completed and sponsored by Northwestern University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Istodax (romidepsin)

Snippet

Sponsor: Northwestern University | Conditions: Cutaneous T-cell Lymphoma | Status: COMPLETED